Macrogenics share price today

(MGNX)

Macrogenics share price is $3.26 & ₹277.75 as on 25 Dec 2024, 2.30 'hrs' IST

$3.26

▲

0.03

(0.93%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Macrogenics share price in Dollar and Rupees. Guide to invest in Macrogenics from India. Also see the sentimental analysis on Indian investors investing in Macrogenics. Get details on the Indian mutual funds that are investing in Macrogenics. Get Analyst recommendations and forecasts along with all the Macrogenics's financials.

Macrogenics share price movements

Today's Low: $3.14
Today's High: $3.26
$3.26
3.68%
Downside
Day's Volatility :3.68%
Upside
0.0%
52 Weeks Low: $2.95
52 Weeks High: $21.88
$3.26
9.48%
Downside
52 Weeks Volatility :86.51%
Upside
85.1%

Macrogenics Returns

Period	Macrogenics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	7.24%	-9.0%	0.0%
6 Months	-20.87%	-4.6%	0.0%
1 Year	-67.27%	3.0%	0.0%
3 Years	-80.55%	0.0%	-21.1%

Macrogenics Key Statistics

in dollars & INR

Previous Close	$3.23
Open	$3.22
Today's High	$3.26
Today's Low	$3.14
Market Capitalization	$204.6M
Today's Volume	$185.0K
52 Week High	$21.88
52 Week Low	$2.9511
Revenue TTM	$141.3M
EBITDA	$-99.7M
Earnings Per Share (EPS)	$-1.57
Profit Margin	-69.07%
Quarterly Earnings Growth YOY	2.21%
Return On Equity TTM	-62.17%

How to invest in Macrogenics from India?

It is very easy for Indian residents to invest directly in Macrogenics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Macrogenics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Macrogenics or MGNX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Macrogenics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Macrogenics shares which would translate to 0.261 fractional shares of Macrogenics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Macrogenics, in just a few clicks!

Returns in Macrogenics for Indian investors in Rupees

Investment Value

₹1,00,000

Macrogenics investment value today

Current value as on today

₹34,970

Returns

₹65,030

(-65.03%)

Returns from Macrogenics Stock

₹67,269 (-67.27%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Macrogenics

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Macrogenics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 0% more investors are searching Macrogenics in the last 30 days versus the previous period.

Global Institutional Holdings in Macrogenics

Bellevue Group AG
15.82%
Armistice Capital, LLC
9.97%
BlackRock Inc
8.61%
Vanguard Group Inc
6.94%
Millennium Management LLC
5.63%
Wasatch Advisors LP
4.04%

Analyst Recommendation on Macrogenics

Buy

88%Buy

11%Hold

0%Sell

Based on 18 Wall street analysts offering stock ratings for Macrogenics(by analysts ranked 0 to 5 stars)

Based on 18 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Macrogenics

What analysts predicted

Upside of 126.23%

Current:

$3.26

Target:

$7.38

Insights on Macrogenics

Price Movement
In the last 1 year, MGNX stock has moved down by -67.8%
Increasing Revenue
Revenue is up for the last 3 quarters, 9.10M → 110.70M (in $), with an average increase of 53.0% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -55.66M → 56.30M (in $), with an average increase of 198.9% per quarter
MGNX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 95.0%
MGNX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 106.4%
Price to Sales
ForMGNX every $1 of sales, investors are willing to pay $1.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Macrogenics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$60.1M	↓ 61.34%
Net Income	$-171.5M	↑ 773.6%
Net Profit Margin	-285.18%	↓ 272.56%

	FY19	Y/Y Change
Revenue	$62.0M	↑ 3.17%
Net Income	$-151.8M	↓ 11.46%
Net Profit Margin	-244.76%	↑ 40.42%

	FY20	Y/Y Change
Revenue	$97.8M	↑ 57.62%
Net Income	$-117.8M	↓ 22.42%
Net Profit Margin	-120.48%	↑ 124.28%

	FY21	Y/Y Change
Revenue	$75.6M	↓ 22.63%
Net Income	$-190.9M	↑ 62.04%
Net Profit Margin	-252.31%	↓ 131.83%

	FY22	Y/Y Change
Revenue	$151.9M	↑ 100.87%
Net Income	$-120.0M	↓ 37.11%
Net Profit Margin	-78.99%	↑ 173.32%

	FY23	Y/Y Change
Revenue	$58.7M	↓ 61.33%
Net Income	$-9.1M	↓ 92.45%
Net Profit Margin	-15.42%	↑ 63.57%

	Q2 FY23	Q/Q Change
Revenue	$13.1M	↓ 45.75%
Net Income	$57.5M	↓ 250.25%
Net Profit Margin	437.49%	↑ 595.45%

	Q3 FY23	Q/Q Change
Revenue	$10.4M	↓ 20.85%
Net Income	$17.6M	↓ 69.45%
Net Profit Margin	168.84%	↓ 268.65%

	Q4 FY23	Q/Q Change
Revenue	$10.7M	↑ 3.11%
Net Income	$-46.1M	↓ 362.46%
Net Profit Margin	-429.78%	↓ 598.62%

	Q1 FY24	Q/Q Change
Revenue	$9.1M	↓ 15.07%
Net Income	$-52.2M	↑ 13.28%
Net Profit Margin	-573.26%	↓ 143.48%

	Q2 FY24	Q/Q Change
Revenue	$10.8M	↑ 18.6%
Net Income	$-55.7M	↑ 6.66%
Net Profit Margin	-515.55%	↑ 57.71%

	Q3 FY24	Q/Q Change
Revenue	$110.7M	↑ 925.36%
Net Income	$56.3M	↓ 201.16%
Net Profit Margin	50.86%	↑ 566.41%

	FY18	Y/Y Change
Profit	$60.1M	↓ 61.34%

	FY19	Y/Y Change
Profit	$-133.3M	↓ 321.69%

	FY20	Y/Y Change
Profit	$97.8M	↓ 173.35%

	FY21	Y/Y Change
Profit	$73.0M	↓ 25.34%

	FY22	Y/Y Change
Profit	$144.6M	↑ 98.04%

	FY23	Y/Y Change
Profit	$50.5M	↓ 65.05%

	Q2 FY23	Q/Q Change
Profit	$12.0M	↓ 42.2%

	Q3 FY23	Q/Q Change
Profit	$10.3M	↓ 13.77%

	Q4 FY23	Q/Q Change
Profit	$8.7M	↓ 16.05%

	Q1 FY24	Q/Q Change
Profit	$5.1M	↓ 40.55%

	Q2 FY24	Q/Q Change
Profit	$6.2M	↑ 19.74%

	Q3 FY24	Q/Q Change
Profit	$108.8M	↑ 1665.99%

	FY18	Y/Y Change
Operating Cash Flow	$-153.2M	↓ 1163.76%
Investing Cash Flow	$56.6M	↓ 27.26%
Financing Cash Flow	$105.0M	↑ 197.02%

	FY19	Y/Y Change
Operating Cash Flow	$-134.3M	↓ 12.38%
Investing Cash Flow	$-79.4M	↓ 240.1%
Financing Cash Flow	$120.0M	↑ 14.27%

	FY20	Y/Y Change
Operating Cash Flow	$-111.9M	↓ 16.66%
Investing Cash Flow	$-7.8M	↓ 90.19%
Financing Cash Flow	$174.3M	↑ 45.32%

	FY21	Y/Y Change
Operating Cash Flow	$-143.8M	↑ 28.54%
Investing Cash Flow	$-36.6M	↑ 370.25%
Financing Cash Flow	$122.8M	↓ 29.58%

	FY22	Y/Y Change
Operating Cash Flow	$-87.0M	↓ 39.54%
Investing Cash Flow	$70.7M	↓ 293.16%
Financing Cash Flow	$1.7M	↓ 98.65%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-2.1M	↓ 83.72%
Investing Cash Flow	$-113.5M	↓ 503.9%
Financing Cash Flow	$59.0K	↓ 99.94%

Macrogenics Technicals Summary

Sell

Neutral

Buy

Macrogenics is currently in a neutral trading position according to technical analysis indicators.

Macrogenics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Macrogenics, Inc.	-4.12%	-20.87%	-67.27%	-80.55%	-68.89%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Macrogenics, Inc.	25.32	NA	0.01	-1.38	-0.62	-0.22	NA	1.91
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Macrogenics, Inc.	Buy	$204.6M	-68.89%	25.32	-69.07%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Macrogenics

a career at macrogenics could be waiting for you! please click on "careers" ---------------------------->>> to learn more. macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. macrogenics creates both differentiated molecules that are directed to novel cancer targets, as well as “bio-betters,” which are drugs designed to improve upon marketed medicines. the combination of macrogenics’ technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. these are exciting times at macrogenics and we hope that you will take the opportunity to learn more about our organization, our pipeline and to view our job opportunities!

Organization	Macrogenics
Employees	339
CEO	Dr. Scott Koenig M.D., Ph.D.
Industry	Health Technology

Management People of Macrogenics

Name	Title
Dr. Scott Koenig M.D., Ph.D.	President, CEO & Director
Mr. James Karrels	Senior VP, CFO & Corporate Secretary
Dr. Stephen L. Eck M.D., Ph.D.	Senior VP of Clinical Development & Chief Medical Officer
Mr. Eric Blasius Risser	Chief Operating Officer
Dr. Thomas M. Spitznagel Ph.D.	Senior Vice President of Technical Operations
Dr. Ezio Bonvini M.D.	Senior VP of Research & Chief Scientific Officer
Mr. Jeffrey Stuart Peters J.D.	Senior VP, General Counsel & Corporate Compliance Officer
Ms. Lynn Cilinski	VP, Controller & Treasurer

Important FAQs about investing in Macrogenics from India :

What is Macrogenics share price today?

Macrogenics share price today stands at $3.26, Open: $3.22 ; Previous Close: $3.23 ; High: $3.26 ; Low: $3.14 ; 52 Week High: $21.88 ; 52 Week Low: $2.95. The stock opens at $3.22, after a previous close of $3.23. The stock reached a daily high of $3.26 and a low of $3.14, with a 52-week high of $21.88 and a 52-week low of $2.95.

Can Indians buy Macrogenics shares?

Yes, Indians can invest in the Macrogenics (MGNX) from India.

With INDmoney, you can buy Macrogenics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Macrogenics at zero transaction cost.

How can I buy Macrogenics shares from India?

It is very easy to buy Macrogenics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Macrogenics be purchased?

Yes, you can buy fractional shares of Macrogenics with INDmoney app.

What are the documents required to start investing in Macrogenics stocks?

To start investing in Macrogenics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.